Yeah, that is what I'm leaning towards as well. Little late (to close to FDA, etc.) and I do realize they have skin in the game as well. I was just seeing what some people thought - as in terms of the R/S or pulling some move out of left-field.
I really am not sure. I don't think they would pull a R/S; not at these levels anyways. Will see what happens in the near future - I do know they have a lot riding on this FDA approval and $$$ has been a sore spot as of recent. So, I could see them doing anything they have to, to keep this thing alive. With that said, I, could see them looking for a buyer overseas and/or merger over there. If, and I mean, IF thing's do not work out here with the FDA this time around....
GL